Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab
Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine if a change in inflammation or baseline
inflammation seen on the ultrasound is a good indicator of how rheumatoid arthritis patients
respond to TCZ 4mg/kg and whether early prediction of dose escalation is possible by
utilizing ultrasound inflammatory measures.